donald trump on glp 1 Big News: GLP-1 medicine prices drop after US President Trump’s announcement Nov 6 Trump secures Eli Lilly, Novo
Description
What did you do
Clinical-stage obesity-related drugs targeting GLP-1R, GIPR, or GDF-8 through November 2024
This approach aligns with clinical guidance to listen to the body and avoid overexertion during periods of reduced energy intake
The clinical
A shortage of medicines containing GLP-1RAs has been affecting EU Member States since 2022
Acknowledgments This study was funded by the deanship of research, Jordan University of Science and Technology, Irbid, Jordan (grant number 20160138)
